A phase 2, double-blind, placebo-controlled, multicenter clinical trial comparing chemoimmunotherapy (paclitaxel-carboplatin-oregovomab [PCO]) versus chemotherapy (paclitaxel-carboplatin-placebo [PCP]) as neoadjuvant therapy in patients with advanced epithelial ovarian, fallopian tube or peritoneal carcinoma: FLORA-6 study

Autor:	Ravishankar Bellala, T S Ganesan, Anita Ramesh, Neeraj Bhatt, Shilpa Kandipalli, Ashwin Kumar, Vijay Kumar, Kartikeya Jain, Shrikrishna Mandal, Mahesh Kumar Kalloli, Ben Yoon, Sunil Gupta, Srinivasa Rao Jada
Rok vydání:	2023
Zdroj:	Proceedings of the 38th Annual Meeting of Korean Society of Gynecologic Oncology.
DOI:	10.3802/jgo.2023.34.s1.tip07
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::6b8bc9e42270bbfa80981029fc3b2861 https://doi.org/10.3802/jgo.2023.34.s1.tip07 Zobrazit plný text záznamu